Nabriva Therapeutics (NBRVF) Q3 2019 Earnings

12NovExpected
Q4 2018
Q1 2019
Q2 2019
Q3 2019
-0.56
-0.45
-0.35
-0.24

Details

Expected EPS
-0.28
Actual EPS
-0.24
Surprise EPS
0.04
Surprise Percent
+14.29%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.24 per share for Q3 2019.

0 Comments

Share your thoughts